Tuberculosis Market Research Reports & Industry Analysis
The Mantoux test is used in the United States and is endorsed by the American Thoracic Society and Centers for Disease Control and Prevention (CDC). Multiple puncture tests such as the Tine test are not recommended. The Mantoux test is one of the two major tuberculin skin tests for tuberculosis used in the world.
As a replacement for the Mantoux test, several other tests are being developed. QuantiFERON®-TB Gold, manufactured by Cellestis Limited (Carnegie, Victoria, Australia) is a blood test that measures the patient’s immune reactivity to the M. tuberculosis and is useful for initial and serial testing of persons with an increased risk of latent or active tuberculosis infection. Guidelines for the use of QuantiFERON-®TB Gold were released by the CDC in December of 2005. QuantiFERON®-TB Gold is FDA approved in the United States; has CE Mark approval in Europe; and has been approved by the MHLW in Japan. Sputum smears and cultures should be done for acid-fast bacilli if the patient is producing sputum. The preferred method for this is fluorescence microscopy (auramine-rhodamine staining), which is more sensitive than conventional Ziehl- Neelsen staining.
Tuberculosis Industry Research & Market Reports
-
Infectious Disease Diagnostic Testing: World Market Analysis, 2024-2029
... market trends is crucial for healthcare providers, investors, and industry stakeholders. This report offers a detailed analysis of the factors driving growth, including the increasing recognition of infectious diseases as a global health concern. As ... Read More
-
2024-2029 Tuberculosis Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Tuberculosis tests performed in the following market segments: Hospitals - Commercial/Private ... Read More
-
Latent TB Testing Market by Test Type (Tuberculin Skin Test/TST, IGRA Test), Application (Household Contacts (HHC) of Tuberculosis (TB) Patients, People Living with HIV), End User (Diagnostic Labs, Hospitals), Region - Global Forecast to 2029
... The latent TB testing market will rise in value from estimated USD 582.5 million in 2024 to USD 773.4 million in 2029, at a CAGR of 5.8% over the forecast period. Increased funding and grants ... Read More
-
Tuberculosis Treatment Drugs Companies in China
... expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in ... Read More
-
Tuberculosis Treatment Drugs Markets in China
... Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's ... Read More
-
Tuberculosis Treatment Drugs Industry Forecasts - China Focus
... of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the ... Read More
-
TB Diagnostic Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global TB diagnostic market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global TB ... Read More
-
Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2033
... Tests; Cell Culture-Based Tests2) By Disease Stage: Latent Tuberculosis; Active Tuberculosis3) By End User: Hospitals And Diagnostic Laboratories; Physician’s Office Laboratories; Reference Laboratories; Academics And Research FacilitiesCovering: Beckton, Dickinson and Company; Qiagen N.V.; F. Hoffmann-La ... Read More
-
2024 Global Tuberculosis Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Tuberculosis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the ... Read More
-
Infectious Disease Diagnostics
... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Assays & Reagents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$25.8 Billion ... Read More
-
2024 Global Forecast for Tuberculosis Therapeutics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2024 Global Forecast for Tuberculosis (Tb) Diagnostics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Research Report 2024(Status and Outlook)
... parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of ... Read More
-
Anti-Tuberculosis Therapeutics Market Report by Disease Type (Active TB, Latent TB, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2024-2032
... reached US$ 1,445.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,448.5 Million by 2032, exhibiting a growth rate (CAGR) of 5.85% during 2024-2032. The rising healthcare spending, favorable reimbursement ... Read More
-
Tuberculosis Therapeutics
... at a CAGR of 2.7% over the analysis period 2023-2030. Active TB Therapeutics, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$654.3 Million by the end ... Read More
-
Tuberculosis Testing
... at a CAGR of 5.1% over the analysis period 2023-2030. Culture-Based Tests, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$714.5 Million by the end of ... Read More
-
Tuberculosis Diagnostics Market Report by Disease Stage (Latent TB, Active TB), Test Type (Radiographic Test, Laboratory Test, Nucleic Acid Testing, Cytokine Detection Test, Drug Resistance Test, and Others), End-User (Hospitals and Clinics, Diagnostics and Research Laboratories, and Others), and Region 2024-2032
... Laboratories, and Others), and Region 2024-2032 The global tuberculosis diagnostics market size reached US$ 2.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2032, exhibiting a growth ... Read More
-
Global BCG Vaccine for Tuberculosis (TB) Market Research Report 2024(Status and Outlook)
... risk of developing TB. The Global BCG Vaccine for Tuberculosis (TB) Market Size was estimated at USD 397.17 million in 2023 and is projected to reach USD 550.75 million by 2029, exhibiting a CAGR of ... Read More
-
Respiratory Diagnostics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Instruments and Devices, Assays & Reagents, Services & Software), By Test Type (Mechanical Tests, OSA Diagnostic Test, Imaging Tests, Traditional Diagnostic Test, Molecular Diagnostic Tests), By Disease Indication (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Others), By End-Use (Hospitals and Clinics, Diagnostics Laboratory, Others), By Region and Competition, 2019-2029F
... Test, Molecular Diagnostic Tests), By Disease Indication (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Others), By End-Use (Hospitals and Clinics, Diagnostics Laboratory, Others), By Region and Competition, 2019-2029F Global Respiratory Diagnostics Market was valued ... Read More
-
Global Tuberculosis (TB) Diagnostics Competitive Landscape Professional Research Report 2024
... (TST) or Mantoux test, which assesses the immune response to the tuberculosis bacterium. Additionally, molecular tests, such as nucleic acid amplification tests (NAATs) and polymerase chain reaction (PCR) assays, allow for the detection of Mycobacterium ... Read More
-
Global Latent Tuberculosis Infection (LTBI) Testing Competitive Landscape Professional Research Report 2024
... the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis ... Read More
-
Global Tuberculosis Vaccine Treatment Competitive Landscape Professional Research Report 2024
... produce antibodies and cellular immune responses against the tuberculosis bacilli. This vaccine is usually given after birth or in early childhood to prevent the development and spread of TB. Although tuberculin vaccine is a routine ... Read More
-
Global Tuberculosis (TB) Detection Competitive Landscape Professional Research Report 2024
... methods are used for TB detection depending on the suspected type of infection and the resources available. Common TB detection methods include tuberculin skin tests (TST), also known as Mantoux tests, where a small amount ... Read More
-
Vietnam Tuberculosis Therapeutics Market, By Disease Type (Active Tuberculosis and Latent Tuberculosis), By Therapy (First Line Therapy and Second Line Therapy), By Region, Competition, Forecast and Opportunities, 2019-2029F
... USD 25.48 Million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 4.12% through 2029. The Vietnam Tuberculosis Therapeutics Market is primarily driven by several key factors ... Read More
-
Tuberculosis – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Tuberculosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Tuberculosis market report provides current treatment practices, emerging drugs, Tuberculosis market share of the individual ... Read More
Research Assistance
